ARX-788
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ARX-788, covering 2024-08-29 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) [Phase 2]